Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.70NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.17NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.5.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.2.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BF.7.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.13NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BF.7.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.99.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.1 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
KT.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KT.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-23154.8US
JC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.334NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.334NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.359NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.359NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
CK.2.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.2.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
DB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DB.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BW.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BQ.1.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.22NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BE.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EF.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BU.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BU.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.5.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.38NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.5.2.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.34NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BF.7.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.12NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-25520.9US
BF.7.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.19NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used